Labeler
Chiesi USA, Inc. NDC Codes
Chiesi USA, Inc. lists 25 finished drug products in the FDA NDC Directory under NDC labeler code 10122.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Juxtapid, Trimbow, Ferriprox, Elfabrio, Cleviprex, Filsuvez, Lamzede, Mycapssa, Revcovi, Kengreal, Myalept, Bethkis, Curosurf, Zyflo
- Active ingredients
- Lomitapide mesylate, Beclomethasone dipropionate, Formoterol fumarate, Glycopyrrolate, Deferiprone, Pegunigalsidase alfa, Clevidipine, Birch triterpenes, Velmanase alfa-tycv, Octreotide, Elapegademase, Cangrelor
- NDC labeler codes
- 10122
- Strengths
- Formoterol fumarate 4.9 ug/1; Glycopyrrolate 10.6 ug/1; Beclomethasone dipropionate 172 ug/1; Beclomethasone dipropionate 86 ug/1; Deferiprone 1000 mg/1; Clevidipine .5 mg/mL; Lomitapide mesylate 2 mg/1; Birch triterpenes 100 mg/g; Pegunigalsidase alfa 20 mg/10mL; Pegunigalsidase alfa 5 mg/2.5mL; Velmanase alfa-tycv 10 mg/1; Octreotide 20 mg/1; Elapegademase 1.6 mg/mL; Deferiprone 100 mg/mL; Cangrelor 50 mg/1; Metreleptin 11.3 mg/2.2mL; Tobramycin 300 mg/4mL; Lomitapide mesylate 5 mg/1; Lomitapide mesylate 10 mg/1; Lomitapide mesylate 20 mg/1
- Dosage forms
- Capsule, Aerosol, Metered, Injection, Powder, Lyophilized, For solution, Injection, Solution, Concentrate, Tablet, Solution, Emulsion, Gel, Capsule, Delayed release, Tablet, Film coated, Injection, Suspension
- Routes
- Oral, Intravenous, Respiratory (Inhalation), Topical, Intramuscular, Subcutaneous, Endotracheal
- Drug classes (FDA established)
- Microsomal Triglyceride Transfer Protein Inhibitor, Anticholinergic, Cholinergic Muscarinic Antagonist, Corticosteroid, beta2-Adrenergic Agonist, Iron Chelator, Dihydropyridine Calcium Channel Blocker, Somatostatin Analog, P2Y12 Platelet Inhibitor, Leptin Analog, Aminoglycoside Antibacterial, Surfactant, 5-Lipoxygenase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 33
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Trimbowbeclomethasone dipropionate/formoterol fumarate/glycopyrrolate | Beclomethasone dipropionate 172 ug/1 + 2 more ingredients | Aerosol, MeteredRespiratory (Inhalation) | 10122-590 | 10122-0590-02 | — |
| Trimbowbeclomethasone dipropionate/formoterol fumarate/glycopyrrolate | Beclomethasone dipropionate 86 ug/1 + 2 more ingredients | Aerosol, MeteredRespiratory (Inhalation) | 10122-120 | 10122-0120-02 | — |
| Trimbowbeclomethasone dipropionate/formoterol fumarate/glycopyrrolate | Beclomethasone dipropionate 172 ug/1 + 2 more ingredients | Aerosol, MeteredRespiratory (Inhalation) | 10122-121 | 10122-0121-02 | — |
| Trimbowbeclomethasone dipropionate/formoterol fumarate/glycopyrrolate | Beclomethasone dipropionate 86 ug/1 + 2 more ingredients | Aerosol, MeteredRespiratory (Inhalation) | 10122-460 | 10122-0460-02 | — |
| Juxtapidlomitapide mesylate | Lomitapide mesylate 2 mg/1 | CapsuleOral | 10122-402 | 10122-0402-28 | — |
| Filsuvezbirch triterpenes | Birch triterpenes 100 mg/g | GelTopical | 10122-310 | 10122-0310-02 | — |
| Elfabriopegunigalsidase alfa | Pegunigalsidase alfa 20 mg/10mL | Injection, Solution, ConcentrateIntravenous | 10122-160 | 10122-0160-0210122-0160-0510122-0160-10 | — |
| Elfabriopegunigalsidase alfa | Pegunigalsidase alfa 5 mg/2.5mL | Injection, Solution, ConcentrateIntravenous | 10122-165 | 10122-0165-02 | — |
| Lamzedevelmanase alfa-tycv | Velmanase alfa-tycv 10 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 10122-180 | 10122-0180-0210122-0180-0510122-0180-10 | — |
| Mycapssaoctreotide | Octreotide 20 mg/1 | Capsule, Delayed releaseOral | 10122-550 | 10122-0550-28 | — |
| Ferriproxdeferiprone | Deferiprone 1000 mg/1 | TabletOral | 10122-104 | 10122-0104-0110122-0104-05 | — |
| Ferriproxdeferiprone | Deferiprone 1000 mg/1 | Tablet, Film coatedOral | 10122-103 | 10122-0103-05 | — |
| Revcovielapegademase-lvlr | Elapegademase 1.6 mg/mL | InjectionIntramuscular | 10122-502 | 10122-0502-01 | — |
| Ferriproxdeferiprone | Deferiprone 100 mg/mL | SolutionOral | 10122-101 | 10122-0101-50 | — |
| Kengrealcangrelor | Cangrelor 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 10122-620 | 10122-0620-10 | — |
| Myaleptmetreleptin | Metreleptin 11.3 mg/2.2mL | Injection, Powder, Lyophilized, For solutionSubcutaneous | 10122-210 | 10122-0210-02 | — |
| Bethkistobramycin | Tobramycin 300 mg/4mL | SolutionRespiratory (Inhalation) | 10122-820 | 10122-0820-0410122-0820-2810122-0820-56 | — |
| Juxtapidlomitapide mesylate | Lomitapide mesylate 5 mg/1 | CapsuleOral | 10122-405 | 10122-0405-28 | — |
| Juxtapidlomitapide mesylate | Lomitapide mesylate 10 mg/1 | CapsuleOral | 10122-410 | 10122-0410-28 | — |
| Juxtapidlomitapide mesylate | Lomitapide mesylate 20 mg/1 | CapsuleOral | 10122-420 | 10122-0420-28 | — |
| Juxtapidlomitapide mesylate | Lomitapide mesylate 30 mg/1 | CapsuleOral | 10122-430 | 10122-0430-28 | — |
| Cleviprexclevipidine | Clevidipine .5 mg/mL | EmulsionIntravenous | 10122-610 | 10122-0610-10 | — |
| Cleviprexclevipidine | Clevidipine .5 mg/mL | EmulsionIntravenous | 10122-611 | 10122-0611-10 | — |
| Curosurfporactant alfa | Poractant alfa 80 mg/mL | SuspensionEndotracheal | 10122-510 | 10122-0510-0110122-0510-03 | — |
| Zyflozileuton | Zileuton 600 mg/1 | TabletOral | 10122-901 | 10122-0901-12 | — |
Chiesi USA, Inc.: common questions
- What is Chiesi USA, Inc.'s NDC labeler code?
- 10122. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Chiesi USA, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.